Ordering
Available Variants5 mg
CHA.85306-5mg
Price
€121.60
Available – Dispatch in 14 days
25 mg
CHA.85306-25mg
Price
€453.60
Available – Dispatch in 14 days
100 g
CHA.85306-100g
Price
€121.60
Available – Dispatch in 14 days
1 kg
CHA.85306-1kg
Price
€353.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.85306-5mg | €121.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.85306-25mg | €453.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 g | CHA.85306-100g | €121.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 kg | CHA.85306-1kg | €353.60 |
≥98% (HPLC), mGlu5 antagonist,
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C11H8N2SHCl |
|---|---|
| CAS Number | 1186195-60-7 |
| Molecular Weight | 236.72 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329817993 |
| NACRES | NA.77 |
| MDL number | MFCD08458895 |
| Assay | ≥98% (HPLC) |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
MTEP hydrochloride, with a CAS number of 15595-35-4, is a potent and selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5). This compound has been extensively studied for its potential therapeutic applications, particularly in the treatment of neurological and psychiatric disorders. MTEP hydrochloride has been shown to exhibit anxiolytic and anticonvulsant properties, making it a promising candidate for the management of anxiety disorders and epilepsy. Additionally, its ability to modulate glutamatergic neurotransmission has implications for the treatment of other conditions, such as depression and drug addiction. The hydrochloride salt form of MTEP is commonly used in research settings due to its improved solubility and stability, facilitating its use in various in vitro and in vivo studies to further elucidate its pharmacological profile and potential clinical utility.
